I.C. Retires after 12 Years at Camber
On May 3, 2024, we said goodbye to a valued warehouse team member, Indravadan “I.C.” Shah, who retired from Camber after 12 years of exceptional service and dedication. With over two decades of experience in the pharmaceutical industry, I.C. leaves behind a legacy of hard work and commitment that greatly contributed to Camber’s success.
During his tenure with us, I.C. embodied our company’s core values, showing consistent enthusiasm and a collaborative spirit. He appreciated the strong support from colleagues and management, as well as the comprehensive benefits package and corporate culture.
As he enters retirement, I.C. has exciting plans to spend time with family and explore new destinations. He will visit his son and grandchild in Ohio, and he and his wife are looking forward to a 17-day European tour.
We are deeply grateful for everything I.C. has done for Camber. His dedication and positive energy will be missed. We wish him all the best in this new chapter of his life. Here’s to a well-deserved and fulfilling retirement!
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






